Biodesix IncBDSX
▲ ポジティブ資本関連度
Better-than-expected results, raised guidance, and positive clinical validation data drove stock to new high.
資産への影響 5
Biotech & Genomic Medicine
Biodesix Inc
Candel Therapeutics IncCADL
▲ ポジティブ技術関連度
Extended survival data for Aglatimagene and a commercialization agreement with EVERSANA drove stock higher.
Indivior PLC Ordinary SharesINDV
▲ ポジティブ資本関連度
Solid earnings, upbeat guidance, and real-world evidence favoring Sublocade supported stock.
Mirum Pharmaceuticals IncMIRM
▲ ポジティブ資本関連度
Consistent revenue growth, Bluejay Therapeutics acquisition, and positive trial results for Brelovitug and Volixibat drove stock.
Synthetic Biology (non-pharma)
Twist Bioscience CorpTWST
▲ ポジティブ資本関連度
Strong revenue and upcoming quarterly report drove stock to new high.